Aprio Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254K Sell
1,129
-65
-5% -$16.2K 0.01% 530
2025
Q4
$336K Sell
1,194
-11
-0.9% -$2.81K 0.02% 409
2025
Q3
$330K Buy
1,205
+1
+0.1% +$273 0.03% 308
2025
Q2
$311K Sell
1,204
-444
-27% -$106K 0.04% 279
2025
Q1
$369K Buy
+1,648
New +$385K 0.05% 230

Other funds holding RMD

Aprio Wealth Management's RMD Position: Q1 2026 in Review

Aprio Wealth Management reduced its ResMed (RMD) stake by 5.4% in Q1 2026, selling an estimated $16.2K and leaving 1,129 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #530.

Aprio Wealth Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $369K in Q1 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Aprio Wealth Management held 1,129 shares of ResMed worth $254K as of Q1 2026.
  • Aprio Wealth Management sold 65 ResMed shares in Q1 2026, an estimated $16.2K.
  • ResMed made up 0.01% of Aprio Wealth Management's portfolio in Q1 2026, its #530 holding.
  • Aprio Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • Aprio Wealth Management's ResMed position peaked at $369K in Q1 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Aprio Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.